HbA1c measurements allow for projection of renal outcomes

HbA1c measurements allow for projection of renal outcomes - GlucCKD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031687

Enrollment

100000

Registered

2023-04-17

Start date

2023-04-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N08.3

Interventions

Group 1: Single-center retrospective observational study analysing influence of HbA1c on renal outcome. Data was obtained from the University of Freiburg Medical Center, Germany. Inclusion criteria we

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - at least one HbA1c measurement - at least two serum-creatinine measurements - follow-up of at least 12 months - Subjects treated between January 1st, 1997 and September 30th, 2022

Exclusion criteria

Exclusion criteria: Inclusion criteria are not met

Design outcomes

Primary

Measure	Time frame
The primary endpoint was defined as new-onset CKD (CKD stage = 3, starting from CKD stage 1 or 2 or absent CKD).	—

Secondary

Measure	Time frame
Secondary endpoints were defined as (S1) progression of CKD (S1, time to CKD stage = 4-5, starting from CKD stage 3) and (S2) new-onset severe CKD (S2, time to CKD stage = 4-5 from CKD stage 1 or 2, respectively).	—

Countries

Germany

Contacts

Public ContactThomas Welte

Universitätsklinikum Freiburg

thomas.welte@uniklinik-freiburg.de004976127034010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026